Latest Stock Market News

A total of 301,091 shares changed hands on the counter till 11:28AM (IST)

At the December meeting, policymakers opted for a half-point rate hike, following four three-quarter-point moves. But they also signaled another 75 basis points worth of increases this year — more than what Fed watchers had been expecting, given the lower inflation readings in recent months.

Gujarat Themis Biosyn Ltd. key Products/Revenue Segments include Pharmaceuticals, Scrap for the year ending 31-Mar-2022.

The stock quoted a 52-week high price of Rs 440.75 and a 52-week low of Rs 206.1.

“A multi asset approach at this point of time is very interesting for investors rather than a situation like 2020 second half, where equity was the best asset class and that was not interesting and that led us to look for new fund offers whether it was business cycle, ESG or flexicap at that point of time.”

Top stock picks: The brokerage is bullish on private banks, insurance, select industrials, consumer discretionary, automobiles and telcos. Stocks in its portfolio include Maruti Suzuki, M&M, Sun Pharmaceutical, Fortis Healthcare, Bharti Airtel, HDFC Bank, ICICI Bank, Axis Bank and SBI Life Insurance.

"The entire growth hinges on how well the corporate earnings grow despite all the global challenges, the volatility in terms of raw material prices, the metal, the commodity prices going high and then falling off towards the end of the year. Corporate earnings have remained resilient and that is something that one needs to be cognisant of going forward."

“In the majority of the portfolio stocks that we are carrying, we carry good long-term conviction. Even if they do not perform for a couple of years, on a compounded basis, they would perform eventually. We have seen our portfolios compounding in the vicinity of around 25% plus. We are happy with that part of it. Sometimes, some stocks do not appreciate but eventually they catch up in the subsequent period.”

Brokerage firms were majorly positive on the issue, suggesting to subscribe to it, considering the business model. However, a few analysts were skeptical over the company’s business due to rising competition and rich valuations.

Post-acquisition of Magma Fincorp, the Poonawalla group has strengthened its leadership team, accompanied by reorientation of the customer mix, realignment of the product suite, and implementation of stringent credit policies.